CDH2 and carcinoma: In fact, N-cadherin and Vimentin were found to be overexpressed in grade III carcinomas (p = 0.033 and p < 0.0001, respectively) and the triple-negative subtype (p = 0.001 and p < 0.0001, respectively) (Table 3, Figure 1 and Figure 2).